Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Leases (2019 - 2025)

Arcadia Biosciences' Leases history spans 7 years, with the latest figure at $10000.0 for Q2 2025.

  • For Q2 2025, Leases fell 98.05% year-over-year to $10000.0; the TTM value through Jun 2025 reached $10000.0, down 98.05%, while the annual FY2024 figure was $137000.0, 82.7% down from the prior year.
  • Leases reached $10000.0 in Q2 2025 per RKDA's latest filing, down from $19000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $6.4 million in Q2 2021 to a low of $10000.0 in Q2 2025.
  • Average Leases over 5 years is $1.9 million, with a median of $1.5 million recorded in 2023.
  • Peak YoY movement for Leases: increased 13.61% in 2021, then plummeted 98.05% in 2025.
  • A 5-year view of Leases shows it stood at $3.1 million in 2021, then crashed by 40.02% to $1.8 million in 2022, then plummeted by 57.14% to $792000.0 in 2023, then plummeted by 82.7% to $137000.0 in 2024, then plummeted by 92.7% to $10000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Leases are $10000.0 (Q2 2025), $19000.0 (Q1 2025), and $137000.0 (Q4 2024).